These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29125072)

  • 1. Predictors of dependence after MCA ischemic stroke submitted to thrombolysis.
    Ducci RD; Lange MC; Germiniani FMB; Zétola VHF
    Neurol Res; 2018 Feb; 40(2):97-101. PubMed ID: 29125072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of in-hospital mortality and dependence at discharge in patients with MCA stroke with intravenous thrombolysis.
    Ducci RD; Lange MC; Zétola VHF
    Intern Emerg Med; 2017 Jun; 12(4):453-460. PubMed ID: 28028726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Related to Cardioembolism as Major Predictors of Poor Survival after First-Ever Middle Cerebral Artery Stroke Treated with Thrombolysis.
    Ducci RD; Lange MC; Zétola VH; Rundek T
    Cerebrovasc Dis; 2017; 43(3-4):178-185. PubMed ID: 28208130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clot characteristics on computed tomography and response to thrombolysis in acute middle cerebral artery stroke.
    Topcuoglu MA; Arsava EM; Akpinar E
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1363-72. PubMed ID: 25804568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis.
    Liu D; Scalzo F; Starkman S; Rao NM; Hinman JD; Kim D; Ali LK; Saver JL; Noorian AR; Ng K; Liang C; Sheth SA; Yoo B; Liu X; Liebeskind DS;
    Cerebrovasc Dis; 2015; 40(5-6):279-285. PubMed ID: 26513397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Thrombolysis Facilitates Successful Recanalization with Stent-Retriever Mechanical Thrombectomy in Middle Cerebral Artery Occlusions.
    Behme D; Kabbasch C; Kowoll A; Dorn F; Liebig T; Weber W; Mpotsaris A
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):954-9. PubMed ID: 26851970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical deterioration following middle cerebral artery hemodynamic changes after intravenous thrombolysis for acute ischemic stroke.
    Baizabal-Carvallo JF; Alonso-Juarez M; Samson Y
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):254-8. PubMed ID: 23433782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
    Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N;
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Kuliha M; Herzig R; Roubec M; Skoloudík D; Zapletalová J; Köcher M; Král M; Veverka T; Cecháková E; Bártková A; Procházka V; Kaňovský P
    Eur Neurol; 2012; 67(1):52-6. PubMed ID: 22156368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
    Rubiera M; Ribo M; Delgado-Mederos R; Santamarina E; Delgado P; Montaner J; Alvarez-Sabín J; Molina CA
    Stroke; 2006 Sep; 37(9):2301-5. PubMed ID: 16888266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.
    Padjen V; Jovanovic D; Berisavac I; Ercegovac M; Stefanovic Budimkic M; Stanarcevic P; Beslac Bumbasirevic L
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2199-2205. PubMed ID: 25018112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for early neurological deterioration after intravenous thrombolysis of single subcortical infarction in the territory of the middle cerebral artery.
    Zhao M; Zhong X; Du J; He L; Wang J
    Brain Behav; 2023 Dec; 13(12):e3283. PubMed ID: 37849437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.